Tuesday, January 8, 2019

Glenmark Pharma eyes up to 15% consolidated revenue growth over 3 to 5 years

Glenmark Pharma eyes up to 15% consolidated revenue growth over 3 to 5 years Glenmark is targeting a consolidated revenue growth of 12-15 percent over the next 3-5 years, while focusing on margin expansion, the company said.

from Moneycontrol Business News http://bit.ly/2FhrWN9

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...